Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood

Sarfraz A. Memon, Claude Sportes, Francis A. Flomerfelt, Ronald E. Gress, Frances T. Hakim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The analysis of T cell receptor diversity provides a clinically relevant and sensitive marker of repertoire loss, gain, or skewing. Spectratyping is a broadly utilized technique to measure global TCR diversity by the analysis of the lengths of CDR3 fragments in each Vβ family. However the common use of large numbers of T cells to obtain a global view of TCR Vβ CDR3 diversity has restricted spectratyping analyses when limited T-cell numbers are available in clinical setting, such as following transplant regimens. We here demonstrate that one hundred thousand T cells are sufficient to obtain a robust, highly reproducible measure of the global TCR Vβ repertoire diversity among twenty Vβ families in human peripheral blood. We also show that use of lower cell number results not in a dwindling of observed diversity but rather in non-reproducible patterns in replicate spectratypes. Finally, we report here a simple to use but sensitive method to quantify repertoire divergence in patient samples by comparison to a standard repertoire profile we generated from fifteen normal donors. We provide examples using this method to statistically evaluate the changes in the global TCR Vβ repertoire diversity that may take place during T subset immune reconstitution after hematopoietic stem cell transplantation or after immune modulating therapies.

Original languageEnglish (US)
Pages (from-to)84-92
Number of pages9
JournalJournal of Immunological Methods
Volume375
Issue number1-2
DOIs
StatePublished - Jan 31 2012
Externally publishedYes

Fingerprint

T-Cell Antigen Receptor
T-Lymphocytes
Cell Count
Hematopoietic Stem Cell Transplantation
Tissue Donors
Transplants
Therapeutics

Keywords

  • Hematopoietic stem cell transplantation
  • Immune reconstitution
  • Spectratype
  • TCR Vβ CDR3 repertoire diversity in human peripheral blood

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood. / Memon, Sarfraz A.; Sportes, Claude; Flomerfelt, Francis A.; Gress, Ronald E.; Hakim, Frances T.

In: Journal of Immunological Methods, Vol. 375, No. 1-2, 31.01.2012, p. 84-92.

Research output: Contribution to journalArticle

Memon, Sarfraz A. ; Sportes, Claude ; Flomerfelt, Francis A. ; Gress, Ronald E. ; Hakim, Frances T. / Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood. In: Journal of Immunological Methods. 2012 ; Vol. 375, No. 1-2. pp. 84-92.
@article{4aed4f4028764130a9acf86bf16d0648,
title = "Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood",
abstract = "The analysis of T cell receptor diversity provides a clinically relevant and sensitive marker of repertoire loss, gain, or skewing. Spectratyping is a broadly utilized technique to measure global TCR diversity by the analysis of the lengths of CDR3 fragments in each Vβ family. However the common use of large numbers of T cells to obtain a global view of TCR Vβ CDR3 diversity has restricted spectratyping analyses when limited T-cell numbers are available in clinical setting, such as following transplant regimens. We here demonstrate that one hundred thousand T cells are sufficient to obtain a robust, highly reproducible measure of the global TCR Vβ repertoire diversity among twenty Vβ families in human peripheral blood. We also show that use of lower cell number results not in a dwindling of observed diversity but rather in non-reproducible patterns in replicate spectratypes. Finally, we report here a simple to use but sensitive method to quantify repertoire divergence in patient samples by comparison to a standard repertoire profile we generated from fifteen normal donors. We provide examples using this method to statistically evaluate the changes in the global TCR Vβ repertoire diversity that may take place during T subset immune reconstitution after hematopoietic stem cell transplantation or after immune modulating therapies.",
keywords = "Hematopoietic stem cell transplantation, Immune reconstitution, Spectratype, TCR Vβ CDR3 repertoire diversity in human peripheral blood",
author = "Memon, {Sarfraz A.} and Claude Sportes and Flomerfelt, {Francis A.} and Gress, {Ronald E.} and Hakim, {Frances T.}",
year = "2012",
month = "1",
day = "31",
doi = "10.1016/j.jim.2011.09.012",
language = "English (US)",
volume = "375",
pages = "84--92",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood

AU - Memon, Sarfraz A.

AU - Sportes, Claude

AU - Flomerfelt, Francis A.

AU - Gress, Ronald E.

AU - Hakim, Frances T.

PY - 2012/1/31

Y1 - 2012/1/31

N2 - The analysis of T cell receptor diversity provides a clinically relevant and sensitive marker of repertoire loss, gain, or skewing. Spectratyping is a broadly utilized technique to measure global TCR diversity by the analysis of the lengths of CDR3 fragments in each Vβ family. However the common use of large numbers of T cells to obtain a global view of TCR Vβ CDR3 diversity has restricted spectratyping analyses when limited T-cell numbers are available in clinical setting, such as following transplant regimens. We here demonstrate that one hundred thousand T cells are sufficient to obtain a robust, highly reproducible measure of the global TCR Vβ repertoire diversity among twenty Vβ families in human peripheral blood. We also show that use of lower cell number results not in a dwindling of observed diversity but rather in non-reproducible patterns in replicate spectratypes. Finally, we report here a simple to use but sensitive method to quantify repertoire divergence in patient samples by comparison to a standard repertoire profile we generated from fifteen normal donors. We provide examples using this method to statistically evaluate the changes in the global TCR Vβ repertoire diversity that may take place during T subset immune reconstitution after hematopoietic stem cell transplantation or after immune modulating therapies.

AB - The analysis of T cell receptor diversity provides a clinically relevant and sensitive marker of repertoire loss, gain, or skewing. Spectratyping is a broadly utilized technique to measure global TCR diversity by the analysis of the lengths of CDR3 fragments in each Vβ family. However the common use of large numbers of T cells to obtain a global view of TCR Vβ CDR3 diversity has restricted spectratyping analyses when limited T-cell numbers are available in clinical setting, such as following transplant regimens. We here demonstrate that one hundred thousand T cells are sufficient to obtain a robust, highly reproducible measure of the global TCR Vβ repertoire diversity among twenty Vβ families in human peripheral blood. We also show that use of lower cell number results not in a dwindling of observed diversity but rather in non-reproducible patterns in replicate spectratypes. Finally, we report here a simple to use but sensitive method to quantify repertoire divergence in patient samples by comparison to a standard repertoire profile we generated from fifteen normal donors. We provide examples using this method to statistically evaluate the changes in the global TCR Vβ repertoire diversity that may take place during T subset immune reconstitution after hematopoietic stem cell transplantation or after immune modulating therapies.

KW - Hematopoietic stem cell transplantation

KW - Immune reconstitution

KW - Spectratype

KW - TCR Vβ CDR3 repertoire diversity in human peripheral blood

UR - http://www.scopus.com/inward/record.url?scp=84855350517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855350517&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2011.09.012

DO - 10.1016/j.jim.2011.09.012

M3 - Article

VL - 375

SP - 84

EP - 92

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -